Search Browse Earnings

THERALINK TECHNOLOGIES, INC.

OTC:THER

Pharmaceutical Preparations·BATON ROUGE, LA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Ruxin Michael I

CFO

Chilcott, Iii Thomas E.

Revenue

$567,905

+12.3% YoY

FY 2023

Adj. EBITDA

-$11.5M

-2024.2% margin

FY 2023

Net Income

-$12.7M

-2243.7% margin

FY 2023

EPS (Diluted)

$0.00

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$0

FY 2014

Total Debt

$250,000

FY 2023

Net Debt

$250,000

FY 2023

Enterprise Value

—

Debt / EBITDA

-0.0x

FY 2023

EV / EBITDA

—

Employees

—